These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6403565)

  • 1. Gonadotropin-releasing hormone agonist suppresses ovulation, menses, and endometriosis in monkeys: an individualized, intermittent regimen.
    Werlin LB; Hodgen GD
    J Clin Endocrinol Metab; 1983 Apr; 56(4):844-8. PubMed ID: 6403565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovulation inhibition by administration of weekly gonadotropin-releasing hormone antagonist.
    Kenigsberg D; Hodgen GD
    J Clin Endocrinol Metab; 1986 Apr; 62(4):734-8. PubMed ID: 3081571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of endometriosis in monkeys: effectiveness of continuous infusion of a gonadotropin-releasing hormone agonist compared to treatment with a progestational steroid.
    Mann DR; Collins DC; Smith MM; Kessler MJ; Gould KG
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1277-83. PubMed ID: 3097054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function.
    Zelinski-Wooten MB; Lanzendorf SE; Wolf DP; Chandrasekher YA; Stouffer RL
    J Clin Endocrinol Metab; 1991 Sep; 73(3):577-83. PubMed ID: 1908481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular stimulation versus ovulation induction in juvenile primates: importance of gonadotropin-releasing hormone dose.
    Sopelak VM; Collins RL; Hodgen GD
    J Clin Endocrinol Metab; 1986 Mar; 62(3):557-62. PubMed ID: 3080466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis.
    Meldrum DR; Chang RJ; Lu J; Vale W; Rivier J; Judd HL
    J Clin Endocrinol Metab; 1982 May; 54(5):1081-3. PubMed ID: 6801075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiovulatory actions of RU 486: the pituitary is not the primary site of action in vivo.
    Heikinheimo O; Gordon K; Lähteenmäki P; Williams RF; Hodgen GD
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1859-68. PubMed ID: 7775633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. II. Progesterone receptor expression in luteinizing granulosa cells.
    Chandrasekher YA; Brenner RM; Molskness TA; Yu Q; Stouffer RL
    J Clin Endocrinol Metab; 1991 Sep; 73(3):584-9. PubMed ID: 1908482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
    Nillius SJ; Bergquist C; Wide L
    Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B; Young J; Brailly S; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexible protocol for administration of human follicle-stimulating hormone with gonadotropin-releasing hormone antagonist.
    Byrd S; Itskovitz J; Chillik C; Hodgen GD
    Fertil Steril; 1992 Jan; 57(1):209-14. PubMed ID: 1730319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin).
    Schriock E; Monroe SE; Henzl M; Jaffe RB
    Fertil Steril; 1985 Nov; 44(5):583-8. PubMed ID: 2932349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
    Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C
    Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human menopausal gonadotropin stimulation in monkeys: blockade of the luteinizing hormone surge by a highly transient ovarian factor.
    Littman BA; Hodgen GD
    Fertil Steril; 1984 Mar; 41(3):440-7. PubMed ID: 6421627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of a GnRH agonist, leuprolide acetate, into regimens with exogenous gonadotropins to produce ovarian stimulation and ovulation in the nonpregnant squirrel monkey.
    Kuehl TJ; Davis TW; Young C; Nunez P; Robinson MR; Huddleston KP; Wincek TJ; Pliego JF; Dukelow WR
    Am J Primatol; 1999 Oct; 49(2):153-64. PubMed ID: 10466574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent GnRH antagonist plus progestin contraception conserving tonic ovarian estrogen secretion and reducing progestin exposure.
    Danforth DR; Williams RF; Hsiu JG; Roh SI; Hahn D; McGuire JL; Hodgen GD
    Contraception; 1990 Jun; 41(6):623-31. PubMed ID: 2113850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.